Acute Exercise Intensity Responses in Women Who Smoke
High-Intensity Treadmill Exercise Elicits Greater Acute Cardiovascular Workload Without Detectable Respiratory or Cognitive Advantage in Female Healthcare Professionals Who Smoke: A Randomized Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
Cigarette smoking is associated with adverse cardiovascular, respiratory, and cognitive effects. Acute aerobic exercise may influence cardiovascular workload, respiratory function, and cognitive performance; however, evidence comparing the immediate effects of different exercise intensities in people who smoke remains limited. This randomized controlled trial investigated the immediate effects of a single high-intensity versus low-intensity treadmill exercise session on rate-pressure product, spirometric outcomes, and cognitive performance in female healthcare professionals working in special education settings who smoke. The study provides information on the immediate cardiovascular, respiratory, and cognitive responses to different intensities of treadmill exercise in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2024
CompletedFirst Submitted
Initial submission to the registry
January 28, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2025
CompletedJuly 17, 2026
July 1, 2026
1.3 years
January 28, 2025
July 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate-Pressure Product (RPP)
Rate-pressure product (RPP) is calculated by multiplying heart rate (beats/min) by systolic blood pressure (mmHg) and dividing the result by 100. RPP provides an index of myocardial oxygen demand and cardiac workload. There is no fixed minimum or maximum value. Higher RPP values indicate greater myocardial workload and oxygen consumption.
Duration of change in 1 day.
Secondary Outcomes (5)
The Fagerström Test for Nicotine Dependence (FTND)
Duration of change in 1 day.
Cognitive status measurement with MOCA
Duration of change in 1 day.
Cognitive status measurement with Stroop Test
Duration of change in 1 day.
FEV1 Measurement
Duration of change in 1 day.
FVC Measurement
Duration of change in 1 day.
Study Arms (2)
high-intensity aerobic exercise group
EXPERIMENTALlow-intensity aerobic exercise group
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Current cigarette smoking, irrespective of nicotine dependence level
- Voluntary agreement to participate in the study
- Completion of the Fagerström Test for Nicotine Dependence
- Absence of a known medical condition that would contraindicate treadmill exercise or interfere with cardiopulmonary assessment
You may not qualify if:
- Diagnosed cardiac or pulmonary disease
- Orthopedic, neurological, vestibular, or systemic disease that could affect exercise performance
- Use of bronchodilator medication
- Orthopedic or cardiopulmonary surgery within the preceding year
- Pregnancy
- Clinically relevant sensory loss
- Leg-length discrepancy that could affect exercise performance
- Participation in another clinical study during the preceding month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Medipol University Hospitallead
- Istanbul Gedik Universitycollaborator
Study Sites (1)
Istanbul Gedik University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 3, 2025
Study Start
September 3, 2023
Primary Completion
December 3, 2024
Study Completion
November 15, 2025
Last Updated
July 17, 2026
Record last verified: 2026-07